New stapled lipopeptide platform offers pan-inhibitors of SARS-CoV-2 and other viruses
Jan. 23, 2024
Several highly pathogenic viruses, including SARS-CoV-2, share a conserved mechanism of infection via the fusion of the viral and host membranes employing a six-helix bundle (6-HB) heptad repeat.